# China NMPA Drug Inspection - Fujian Pacific Pharmaceutical Co., Ltd. - Ibuprofen sustained-release capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/fujian-pacific-pharmaceutical-co-ltd/32436f2c-1727-48a0-a1dc-32bc3babefb4/
Source feed: China

> China NMPA drug inspection for Fujian Pacific Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Ibuprofen sustained-release capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Fujian Pacific Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Ibuprofen sustained-release capsules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/fujian-pacific-pharmaceutical-co-ltd/b1f6ad34-be39-4059-917f-8992893a9f76/